Inventor
Kiyean NAM
Inventor
KR
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds28%
C07BGeneral methods of organic chemistry6%
PatentTitleYear
12,582,598Topical anti-inflammatory pharmaceutical composition comprising Zileuton202612,410,165Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide202512,162,858Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1R202411,945,822Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase202411,858,937Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors202411,447,4862-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to QURIENT CO LTD (6)· patent assignee history
2022Patents assigned to PASTEUR INSTITUT KOREA (1)· patent assignee history
2022–2026Based in KR· patent location history
2024Patents assigned to LEAD DISCOVERY CENTER GMBH (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| QURIENT CO LTD | 6 | 2022–2026 |
| LEAD DISCOVERY CENTER GMBH | 2 | 2024 |
| PASTEUR INSTITUT KOREA | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 6 | 2022–2026 |